✦ LIBER ✦

Neuroleptic malignant syndrome without rigidity

✍ Scribed by Franco Benazzi

Publisher: Springer Milan
Year: 1991
Tongue: English
Weight: 72 KB
Volume: 12
Category: Article
ISSN: 1590-1874
DOI: 10.1007/bf02337625

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroleptic malignant syndrome

✍ Tsong-Hai Lee; Lok-Ming Tang 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 417 KB

Postoperative neuroleptic malignant synd

Postoperative neuroleptic malignant syndrome

✍ M. Joanne Douglas; P. Patel; G Bristow 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 French ⚖ 66 KB

Neuroleptic malignant syndrome and catat

Neuroleptic malignant syndrome and catatonia

✍ Michele Raja; Maria Concetta Altavista; Stefano Cavallari; Loredana Lubich 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 611 KB

Rhabdomyolysis without neuroleptic malig

Rhabdomyolysis without neuroleptic malignant syndrome induced by additional treatment of risperidone

✍ Norio Yasui; Tsuyoshi Kondo; Koichi Otani; Sunao Kaneko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

This is the ®rst case report of rhabdomyolysis without neuroleptic malignant syndrome induced by additional treatment of risperidone. The manifestations of this side eect were symptoms of myalgia, muscle weakness and redcoloured urine with ®ndings of markedly elevated levels of creatine kinase and m

Neoplasia and the neuroleptic malignant

Neoplasia and the neuroleptic malignant syndrome

✍ P. W. R. Wooduff; E. Palazidou; I. Cranston; B. K. Toone; B. Summers; A. L. W. F 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

## Abstract The association of neuroleptic malignant syndrome with neoplasia has not been previously reported. We report the case of a 64‐year‐old female patient who developed the classical picture of neuroleptic malignant syndrome in relation to a uterine leiomyosarcoma. This raises the question a

Clinical risk factors for neuroleptic ma

Clinical risk factors for neuroleptic malignant syndrome

✍ Domenico Berardi; Maddalena Dell'Atti; Mario Amore; Diana De Ronchi; Giuseppe Fe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

Pharmacological risk factors for neuroleptic malignant syndrome (NMS) are better defined than clinical risk factors. We examined the psychopathological status preceding the onset of NMS in 20 patients. We evaluated four key psychiatric symptoms (psychomotor agitation, catatonia, disorganization and